ELTX
Elicio Therapeutics·NASDAQ
--
--(--)
--
--(--)
ELTX fundamentals
Elicio Therapeutics (ELTX) released its earnings on Nov 13, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.6 (YoY +56.83%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-0.6
+56.83%
Report date
Nov 13, 2025
EPS
Actual | -19 | -15.6 | -5.8 | -5.3 | 5 | -4.8 | -3 | -3 | -2.61 | -1.27 | -1.25 | -1.15 | -0.64 | -1.39 | -1.07 | -0.87 | -0.66 | -0.6 | |
Forecast | -13.225 | -6.225 | -6.875 | -7.25 | -3.275 | -4.35 | -4.6333 | -3.2 | -5.4 | -5.7 | -0.8 | -1.03 | -1.09 | -0.96 | -0.73 | -0.875 | -0.83 | -0.685 | -0.48 |
Surprise | -43.67% | -150.60% | +15.64% | +26.90% | +252.67% | -10.34% | +35.25% | +6.25% | 0.00% | +54.21% | -58.75% | -21.36% | -5.50% | +33.33% | -90.41% | -22.29% | -4.82% | +3.65% | -25.00% |
Revenue
Actual | 479.50K | 371.00K | 540.00K | 1.46M | 25.90M | 1.65M | 653.00K | 0 | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Forecast | 753.00K | 1.89M | 787.50K | 1.06M | 7.41M | 918.75K | 1.35M | 625.00K | 800.00K | 800.00K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Surprise | -36.32% | -80.34% | -31.43% | +37.41% | +249.52% | +79.37% | -51.63% | -100.00% | 0.00% | -100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What does Elicio Therapeutics do and what are its main business segments?What factors drove the changes in Elicio Therapeutics's revenue and profit?What were the key takeaways from Elicio Therapeutics's earnings call?Did Elicio Therapeutics beat or miss consensus estimates last quarter?What guidance did Elicio Therapeutics's management provide for the next earnings period?What is Elicio Therapeutics's latest dividend and current dividend yield?What is the market's earnings forecast for Elicio Therapeutics next quarter?What is Elicio Therapeutics's gross profit margin?
